Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

被引:6
|
作者
Jensen, Christoph J. [1 ]
Naber, Christoph K. [1 ]
Urban, Philip [2 ]
Ong, Paul J. [3 ]
Valdes-Chavarri, Mariano [4 ]
Abizaid, Alexandre A. [5 ]
Pocock, Stuart J. [6 ]
Fabbiocchi, Franco [7 ]
Dubois, Christophe [8 ]
Copt, Samuel [9 ]
Stoll, Hans-Peter [9 ]
Morice, Marie-Claude [10 ]
机构
[1] Elisabeth Krankenhaus Essen, Contilia Heart & Vasc Ctr, Essen, Germany
[2] Hosp la Tour, Geneva, Switzerland
[3] Tan Tock Seng Hosp, Singapore, Singapore
[4] Hosp Univ Virgen de la Arrixaca, Murcia, Spain
[5] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
[6] London Sch Hyg & Trop Med, London, England
[7] Ctr Cardiol Monzino, Milan, Italy
[8] Univ Ziekenhuizen Leuven, Dept Cardiovasc Med, Leuven, Belgium
[9] Biosensors Europe, Morges, Switzerland
[10] CERC, Massy, France
关键词
2017; ESC;
D O I
10.4244/EIJ-D-17-00720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1946 / 1949
页数:4
相关论文
共 48 条
  • [42] Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial
    Mehran, Roxana
    Chandrasekhar, Jaya
    Urban, Philip
    Lang, Irene M.
    Windhoevel, Ute
    Spaulding, Christian
    Copt, Samuel
    Stoll, Hans-Peter
    Morice, Marie-Claude
    JAMA CARDIOLOGY, 2020, 5 (08) : 939 - 947
  • [43] Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents in Acute Coronary Syndrome Patients With High Ischemic Risk: Three-Year Post Hoc Analysis of the HOST-REDUCE-POLYTECH-ACS Trial
    Han, Seokmoon
    Hwang, Doyeon
    Kang, Jeehoon
    Park, Kyung Woo
    Han, Jung-Kyu
    Yang, Han-Mo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B127 - B128
  • [44] Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy
    Urban, Philip
    Abizaid, Alex
    Chevalier, Bernard
    Greene, Samantha
    Meredith, Ian
    Morice, Marie-Claude
    Pocock, Stuart
    AMERICAN HEART JOURNAL, 2013, 165 (05) : 704 - 709
  • [45] Impacts of renin-angiotensin system inhibitors on two-year clinical outcomes in diabetic and dyslipidemic acute myocardial infarction patients after a successful percutaneous coronary intervention using newer-generation drug-eluting stents
    Kim, Yong Hoon
    Her, Ae-Young
    Jeong, Myung Ho
    Kim, Byeong-Keuk
    Hong, Sung-Jin
    Kim, Seunghwan
    Ahn, Chul-Min
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    MEDICINE, 2020, 99 (30) : E21289
  • [46] Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom™ drug-coated stent vs. the Gazelle™ bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy
    Stefanini, Giulio G.
    Behan, Miles
    Valgimigli, Marco
    Oldroyd, Keith G.
    Leon, Martin B.
    EUROINTERVENTION, 2016, 12 (06) : 798 - 800
  • [47] Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry
    Kim, Yong Hoon
    Her, Ae-Young
    Jeong, Myung Ho
    Kim, Byeong-Keuk
    Shin, Dong-Ho
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (07) : 1264 - 1275
  • [48] Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitusResults of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial
    Tobias Koch
    Tobias Lenz
    Michael Joner
    Erion Xhepa
    Tobias Koppara
    Jens Wiebe
    J. J. Coughlan
    Alp Aytekin
    Tareq Ibrahim
    Thorsten Kessler
    Salvatore Cassese
    Karl-Ludwig Laugwitz
    Heribert Schunkert
    Adnan Kastrati
    Sebastian Kufner
    Clinical Research in Cardiology, 2021, 110 : 1586 - 1598